ArticleThe oncologist2026
Female sex is associated with worse survival in laryngeal head and neck squamous cell carcinoma.
Article in The oncologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic and Clinical-Nutritional Correlation Patterns in Relation to 3-Year Disease-Free Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Preliminary Analysis.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundDespite treatment, approximately one-third of patients with head and neck squamous cell carcinoma (HNSCC) die within 5 years of diagnosis. Here, we assessed molecular and clinical features that correlate with biological sex and overall survival in HNSCC.
methodsWe analyzed HNSCC cases in The Cancer Genome Atlas, which includes tumors from 382 males and 141 females. When possible, findings were validated with the National Cancer Institute's Surveillance, Epidemiology, and End Results dataset (November 2023 Submission, 1975-2021).
resultsTumors from females had a significantly lower fraction of genome altered, along with fewer aneuploidy events. HNSCCs in females had increased expression of immune genes and higher overall immune infiltrate. Females showed worse overall survival in HNSCC compared to males (hazard ratio [HR]: 1.39). This disparity was statistically attributable to age at diagnosis as well as HPV status, as HNSCCs in females were less likely to be HPV-positive than in males. For laryngeal squamous cell carcinoma (L-HNSCC), females also had significantly worse outcomes (HR: 3.42), but here the disparity could not be attributed to available clinicogenomic features such as HPV or smoking status. The association of biological sex with outcome in L-HNSCC was also observed in the SEER database and was not present among patients diagnosed before the age of 50.
conclusionBiological sex is associated with differences in survival and tumor genomic features in HNSCC. HPV infection status, diagnosis age, and tumor location contribute to a worse prognosis for females with HNSCC, particularly strong in L-HNSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.